Initial Treatment Approach for Frontal Alopecia
For frontal fibrosing alopecia (FFA), the initial treatment approach should include 5-α-reductase inhibitors, intralesional corticosteroids, or hydroxychloroquine, as these have the highest level of evidence for disease stabilization. 1
Understanding Frontal Alopecia
Frontal alopecia can refer to different conditions, with frontal fibrosing alopecia (FFA) being the most common specific entity. FFA is a cicatricial (scarring) alopecia characterized by:
- Progressive recession of the frontotemporal hairline
- Band-like pattern of hair loss
- Perifollicular erythema
- Lighter skin in the affected area compared to the forehead
- Frequent loss of eyebrows
- "Lonely hair" sign (isolated terminal hairs within areas of hair loss)
Diagnostic Approach
Before initiating treatment, proper diagnosis is essential:
- Clinical examination: Look for band-like recession of frontotemporal hairline, perifollicular erythema, and eyebrow loss 2
- Trichoscopy: Essential for all hair diseases to identify specific patterns 3
- Scalp biopsy: May be necessary in unclear cases, though clinical diagnosis is often sufficient 2
Treatment Algorithm for Frontal Fibrosing Alopecia
First-line options (choose based on patient factors):
5-α-reductase inhibitors:
- Finasteride (1-2.5mg daily) or dutasteride (0.5mg daily)
- Highest level of evidence for disease stabilization 1
- More suitable for postmenopausal women (most common demographic)
Intralesional corticosteroids:
- Triamcinolone acetonide (5-10mg/mL) injected into active inflammatory areas
- Particularly effective for controlling inflammation and symptoms 4
- Administer at 4-6 week intervals
Hydroxychloroquine:
- 200-400mg daily
- May take 6-12 months to show effectiveness 2
- Monitor for ocular toxicity with regular ophthalmologic exams
Adjunctive treatments:
Topical treatments:
- Minoxidil 5% solution/foam (daily application)
- Topical corticosteroids for symptomatic relief of pruritus
- Topical calcineurin inhibitors (tacrolimus, pimecrolimus)
For refractory cases:
- Methotrexate (15-25mg weekly) 2
- Systemic retinoids (acitretin)
- Pioglitazone
Treatment Goals and Expectations
It's crucial to understand that:
- The goal of treatment is disease stabilization rather than hair regrowth due to the scarring nature of FFA 1
- Treatment response should be assessed by:
- Reduction in perifollicular erythema (marker of active disease)
- Cessation of progressive hairline recession
- Improvement in symptoms (pruritus, burning)
Common Pitfalls and Caveats
- Delayed treatment response: Most treatments require 6-12 months before efficacy can be properly assessed
- Spontaneous stabilization: The variable course of FFA can lead to overestimation of treatment effects 2
- Psychological impact: Hair loss significantly impacts quality of life and may cause anxiety and depression 5
- Treatment adherence: Complex regimens may lead to poor compliance; consider simplifying when possible
- Eyebrow restoration: Consider permanent makeup/microblading for eyebrow loss as this rarely responds to medical treatment
Monitoring
- Photographic documentation at baseline and follow-up visits (every 3-6 months)
- Use of validated assessment tools like the Frontal Fibrosing Alopecia Severity Score 2
- Particular attention to perifollicular erythema, which correlates with disease activity 2
Remember that FFA is a chronic condition requiring long-term management and patient education about realistic expectations is essential for treatment success.